ArticleVeterinary medicine and science2025
Evaluation of Testican-1 as a Sepsis Biomarker in Pyometra Cats.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testican-1 is a promising biomarker for sepsis, with potential applications in both diagnosis and treatment monitoring in human medicine. The aim of this study was to evaluate the potential of Testican-1 as a biomarker in feline sepsis, using pyometra as a model for naturally occurring sepsis. The study was conducted on a total of 30 cats from different breeds, aged between 1 and 8 years. The cats were divided into three groups on the basis of the owner's history, physical and gynaecological examination findings, diagnostic ultrasonography results and systemic inflammatory response syndrome (SIRS) criteria. The control group (Group 1, n = 10) consisted of healthy cats without pyometra symptoms, the non-septic pyometra group (Group 2, n = 10) included cats with pyometra but not meeting the SIRS criteria, and the septic pyometra group (Group 3, n = 10) included cats with pyometra that met the SIRS criteria. The obtained data were analysed using one-way ANOVA. It was found that body temperature and pulse values were significantly higher in the non-septic and septic pyometra groups compared to the control group (p < 0.001). Respiratory rate did not show a significant difference between the control group and the non-septic pyometra group (p > 0.05), but it was significantly higher in the septic pyometra group (p < 0.001). White blood cell (WBC) counts were significantly higher in the non-septic and septic pyometra groups compared to the control group (p < 0.001). Glucose, creatinine, and C-reactive protein (CRP) values did not show significant differences between the control group and the non-septic pyometra group (p > 0.05) but were significantly higher in the septic pyometra group (p < 0.001). Serum amyloid A (SAA) and Testican-1 levels were significantly higher in both non-septic and septic pyometra groups compared to the control group (p < 0.001). Correlation analysis showed a significant negative correlation between Testican-1 and heart rate (r = -0.864, p < 0.01) and creatinine (r = -0.584, p < 0.01). In contrast, significant positive correlations were found between Testican-1 and body temperature (r = 0.929, p < 0.01), respiratory rate (r = 0.844, p < 0.01), WBC (r = 0.955, p < 0.01), glucose (r = 0.865, p < 0.01), CRP (r = 0.993, p < 0.01) and SAA (r = 0.971, p < 0.01). In conclusion, it was concluded that Testican-1 could be used as a novel biomarker for the detection of sepsis in pyometra cats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.